Expanded Access to Tavapadon
Status
Conditions
Parkinson Disease
Treatments
Drug: Tavapadon
Details and patient eligibility
About
This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to tavapadon prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.
Sex
All
Volunteers
No Healthy Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
- The participant must not be eligible for a tavapadon clinical trial.
Trial contacts and locations
1
Loading...
Central trial contact
ABBVIE CALL CENTER
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems